INTRODUCTION {#S1}
============

Obesity has reached epidemic proportions throughout the western world in recent years and has become a major health risk factor for a variety of human diseases including cardiovascular diseases, diabetes, and cancer ([@R17]; [@R49]). In particular, a wealth of epidemiological evidence has established a strong association between obesity and higher incidence of breast cancer in postmenopausal women ([@R6]; [@R26]). In fact, it is estimated that approximately 20% of all postmenopausal breast cancer cases can be attributed to overweight and obesity ([@R25]). In addition, a high body mass index (BMI) at disease onset has a well-recognized predictive value for poor prognosis in both pre- and post-menopausal breast cancer patients ([@R7]; [@R48]). In a recent clinical study ([@R10]), obese or overweight patients with locally advanced breast cancer (LABC) had significantly worse survival outcomes and a higher incidence of recurrence compared to patients with lower BMI (\<25). Thus, it is of paramount importance to understand the molecular basis for the association of obesity with breast cancer risk and mortality.

In addition to its function as an energy depot, adipose tissue also serves as a major endocrine organ ([@R1]). Numerous studies have demonstrated that an abundance of growth factors and cytokines is released from adipose tissue and can exert a substantial impact on the progression and outcome of many human diseases, including breast cancer ([@R41]). For instance, breast adipose tissue is an important site for estrogen production among post-menopausal women ([@R9]). Elevated estrogen biosynthesis from intratumoral adipose tissue is thought to contribute to estrogen receptor (ER)-positive, postmenopausal breast cancer ([@R5]; [@R20]). However, a possible estrogen-independent effect of adipose tissue on breast cancer development remains to be elucidated.

Mammary epithelia are surrounded by multiple types of stromal cells including preadipocytes, adipocytes, fibroblasts, vasculature, pericytes, and macrophages ([@R16]). These stromal cells, in concert with the extracellular matrix (ECM), create a microenvironment that tightly controls proliferation and differentiation of epithelial cells ([@R4]). At the onset and during the progression of breast cancer, the tissue microenvironment is reorganized by the tumor cells in order to support tumor cell proliferation and invasion into the surrounding tissue ([@R37]). Numerous studies have shown that tumors recruit stromal fibroblasts in a process referred to as the desmoplasmic reaction ([@R41]). These carcinoma-associated-fibroblasts (CAF) are then reprogrammed to produce growth factors, cytokines, and ECM-remodeling proteins ([@R33]). While adipose tissue-derived cells have been linked with cancer development ([@R8]; [@R45]), much less is known about the molecular basis of the impact of adipose tissue on the behavior of breast tumor cells.

Recent advances in regenerative medicine have led to the discovery of a new adipose cell type termed adipose stromal cells (ASCs) with great developmental plasticity ([@R15]; [@R46]). These cells share characteristics of mesenchymal stem cells (MSCs) isolated from other tissues including the capability to differentiate into multiple cell lineages ([@R28]). Given that bone-marrow-derived MSCs recruited by breast carcinomas promote breast cancer invasion and metastasis ([@R21]), we hypothesized that ASCs might possess a similar tumor-promoting capability. Using *in vitro* co-culture assays and a xenograft model, we studied the effect of ASCs on the migratory and invasive behaviors of tumor cells.

RESULTS {#S2}
=======

ASCs stimulate migration and invasion of breast tumor cells in vitro {#S3}
--------------------------------------------------------------------

ASCs were isolated from adipose tissue obtained by abdominal liposuction or reduction mammoplasty from cancer-free donors using a previously published protocol ([@R22]). These cells were tested in a Boyden-chamber based transmigration assay for their ability to induce migration of ER-positive (MCF-7) and ER-negative breast cancer cells (MDA-MB-231). As a comparison, we included skin fibroblasts that were previously shown to stimulate tumor growth in a xenograft model ([@R29]). The various stromal cells, together with medium alone as the negative control, were seeded in the lower chamber of a Boyden-chamber apparatus 48 hours prior to the assay. Breast cancer cells were subsequently placed into the top chamber and allowed to migrate across the porous membrane. ASCs of both breast and abdominal adipose tissue origins substantially stimulated migration of breast cancer cells, as evidenced by the large number of tumor cells migrating through the membrane in the presence of ASCs ([Fig. 1A](#F1){ref-type="fig"}, top panel). In contrast, skin fibroblasts only gave rise to modest increases in the number of migrated breast cancer cells. ASCs stimulated migration of ER-positive and ER-negative cells to a comparable extent ([Fig. 1A](#F1){ref-type="fig"}), suggesting that the effect of ASCs was estrogen independent. Matrigel-based cell invasion assay demonstrated a similar stimulatory effect of ASCs on tumor cell invasion ([Fig. 1B](#F1){ref-type="fig"}).

Because there was no direct contact between ASCs and breast cancer cells under these assay conditions, an ASC-secreted factor(s) was most likely responsible for the stimulation of tumor cell migration and invasion. In support of this notion, ASC-conditioned medium was sufficient to stimulate tumor cell migration in the Boyden-chamber assay (data not shown, but see below). To complement the Boyden-chamber assay, the ability of ASC-conditioned medium to stimulate tumor cell migration was tested in a "wound-healing" assay, where a "wound" was created in a confluent culture of MDA-MB-231 cells and movement of the tumor cell front into the open space was monitored by live-cell imaging. Tumor cells that were exposed to ASC-conditioned medium displayed a 20% higher velocity than those exposed to control medium (p=0.0001; [Suppl. Fig. 1A](#SD1){ref-type="supplementary-material"}), thus further supporting the existence of an ASC-secreted factor(s) that influences the migratory behavior of breast cancer cells. It is also worth noting that, upon exposure to ASC-conditioned medium, a small number of the tumor cells migrated at a much faster pace than the rest of the cell population ([Suppl. Fig. 1B](#SD1){ref-type="supplementary-material"}). This type of "outlier" cells was not observed in MDA-MB-231 cells treated with control medium.

ASCs stimulate invasion of breast tumor cells in a xenograft model {#S4}
------------------------------------------------------------------

To validate the *in vitro* effect of ASCs on tumor cell behaviors, we used a renal capsule-based xenograft mouse model ([@R29]) to investigate the impact of ASCs on tumor invasion *in vivo*. MDA-MB-231 cells were transplanted alone or with ASCs under the renal kidney capsule of immunodeficient mice (n=4 per treatment). Two weeks after transplantation, tumor development was evaluated by immunohistochemistry of the green fluorescent protein (GFP)-positive tumor cells in the xenograft mouse kidney tissue. As shown in panels a and b in [Fig. 2A](#F2){ref-type="fig"}, MDA-MB-231 cells without ASCs formed a quite even front at the boundary between tumor cells and the mouse kidney tissue. In contrast, MDA-MB-231 cells that were co-transplanted with ASCs did not form a distinct boundary between the xenograft and kidney tissue (panels c and d in [Fig. 2A](#F2){ref-type="fig"}). Rather, tumor cells in this case adopted a quite aggressive phenotype, as evidenced by invasion of finger-like protrusions plus individual tumor cells into the kidney parenchyma. To quantitate the ASC effect, the depth of the invading cell front was taken as an indicator for tumor invasiveness. There was a striking increase in the depth of invasion when ASCs were co-transplanted with the breast tumor cells ([Fig. 2B](#F2){ref-type="fig"}). Taken together, both *in vitro* and *in vivo* findings clearly demonstrate a stimulatory effect of ASCs on the migratory behavior and invasive capability of breast cancer cells.

The stimulatory effect of ASCs involves a cofilin-1-dependent pathway in the stromal cells {#S5}
------------------------------------------------------------------------------------------

To identify the potential molecular players that mediate the effect of ASCs on tumor cell migration, we used an siRNA mini-library that was used in a separate study of ASCs (Ghosh et al., manuscript submitted). The siRNA-transfected ASCs were seeded in the lower chamber of the Boyden-chamber system to assess their effects on the migration of MDA-MB-231 cells. Of all the genes targeted in the siRNA screen, cofilin-1 knockdown resulted in the greatest reduction in the ASC-mediated stimulation of tumor cell migration ([Suppl. Fig, 2](#SD2){ref-type="supplementary-material"}). To ascertain the specificity of the siRNA pool, two independent cofilin-1 siRNA oligos were tested for their effects on ASC-mediated stimulation of tumor cell migration. As shown in [Fig. 3](#F3){ref-type="fig"}, both the siRNA pool and individual oligos were effective in reducing the cofilin-1 expression and the migration-promoting activity of ASCs. Notably, the protein levels of cofilin-1 in the knockdown cell populations correlate well with their ability to stimulate migration of MDA-MB-231 cells.

Cofilin-1 is a key regulator of actin dynamics. It acts by severing actin filaments (F-actin) and thereby creating barbed ends for polymerization and extension of actin filaments as well as increasing available monomeric G-protein ([@R32]), ([@R42]). The activity of cofilin-1 is governed through the coordinated action of several kinases, including RhoA and Rock1 ([@R47]) ([Fig. 4A](#F4){ref-type="fig"}). To ascertain the role of the cofilin-1-dependent pathway in ASC-stimulated tumor cell migration, we knocked down several additional players in the same pathway: N-Wasp, RhoA, Rock1, and Rock2, another member of the Rock family ([Suppl. Fig. 3](#SD3){ref-type="supplementary-material"}). Knockdown of N-Wasp, RhoA or Rock1 consistently reduced the stimulatory activity of ASCs on breast tumor cells ([Fig. 4B](#F4){ref-type="fig"}). In contrast, siRNA knockdown of Rock2, which is not involved in regulation of cofilin-1 activity, did not have as much of an effect on the migration of breast cancer cells ([Fig. 4B](#F4){ref-type="fig"}). In yet another approach to determine the involvement of Rock1 in the ASC-mediated stimulation of breast cancer cell migration, ASCs were pre-treated with a ROCK-specific inhibitor (Y27632). At concentrations that do not affect cell viability, the drug treatment reduced ASC-stimulated migration of breast cancer cells in a dose-dependent manner ([Fig. 4C](#F4){ref-type="fig"}). Taken together, these data indicate that the cofilin-1-dependent pathway in ASCs plays an important role in conferring stimulation of tumor cell migration.

ASC-secreted Interleukin-6 (IL-6) is responsible for the ASC-dependent stimulation of breast cancer cell migration and invasion {#S6}
-------------------------------------------------------------------------------------------------------------------------------

Our data from the in vitro migration and invasion assays strongly suggest the presence of a diffusible factor(s) in ASC-conditioned medium that stimulates tumor cell migration. Furthermore, medium that was conditioned with cofilin-knockdown ASCs exhibited a significantly lower stimulatory activity in the Boyden-chamber assay in comparison with medium from the control knockdown cells ([Fig. 5A](#F5){ref-type="fig"}), suggesting that the cofilin-1 knockdown reduces the production of the putative migration-promoting factor(s).

To identify the putative migration-promoting factor(s), we used conditioned medium from control and cofilin-1-knockdown ASCs to probe an antibody-based cytokine array that is capable of detecting 79 different cytokines and growth factors. To reduce the high background of growth factors and cytokines present in normal fetal bovine serum, the FBS concentration in the ASC-culturing medium was reduced to 1% (v/v). The reduced serum concentration was still sufficient to sustain the ASC-mediated stimulatory effect on tumor cell migration ([Suppl. Fig. 4](#SD4){ref-type="supplementary-material"}). As shown in [Fig. 5B](#F5){ref-type="fig"}, the control ASC-conditioned medium contained a number of cytokines and growth factors at detectable levels. These include ENA-78, ILβ1, IL-6, IL-8, MCP-1, RANTES, VEGF, FGF-4, HGF, TIMP-1, and TIMP-2 ([Fig. 5B](#F5){ref-type="fig"}, left panel). Among all the detected factors, the protein level of IL-6 was most significantly reduced in the cofilin-1-knockdown conditioned medium (arrows in [Fig. 5B](#F5){ref-type="fig"}). Consistent with the result from the cytokine array, the mRNA level of IL-6 was also reduced in the cofilin-1-knockdown ASCs ([Fig. 5C](#F5){ref-type="fig"}).

To determine whether IL-6 contributes to ASC-mediated stimulation of breast tumor cell migration, IL-6 was depleted from the ASC-conditioned medium by an IL-6-specific antibody and the resulting medium was tested for its ability to induce migration of breast cancer cells in the Boyden-chamber assay. As shown in [Fig. 6A](#F6){ref-type="fig"}, IL-6 depletion abrogated the migration-promoting activity of ASCs. As a control, non-conditioned medium that was treated with the IL-6 antibody did not affect breast cancer cell migration, suggesting that the neutralizing effect of the IL-6 antibody was specific to the ASC-conditioned medium. In a similar manner, IL-6 depletion substantially reduced the capability of ASC cells to stimulate invasion of breast cancer cells in the Matrigel-based invasion assay ([Fig. 6B](#F6){ref-type="fig"}). Therefore, our work identifies IL-6 as an important ASC-secreted factor that is responsible for stimulating the migratory and invasive behavior of breast tumor cells.

DISCUSSION {#S7}
==========

Excessive adiposity is a well-documented risk factor for breast cancer. Adipose tissue exerts both paracrine and endocrine effects on breast tumor development. Our study shows that ASCs, a resident cell population in adipose tissue with multipotent potential, provide a potent stimulus for tumor cell migration and invasion *in vitro* and *in vivo*. Because ASCs used in our study were derived from cancer-free individuals and had never been exposed to any tumor milieu, our work suggests that ASCs have an innate ability to promote tumor migration and invasion. Furthermore, we demonstrate that the cofilin-dependent signal transduction pathway has a previously unappreciated function in controlling the production of adipose cell-secreted tumor-promoting factors. Lastly, we provide evidence that ASC-secreted IL-6 is an important factor in promoting tumor cell migration and invasion.

It has been well documented that tumor cells have the ability to recruit stromal cells to the vicinity of the tumor and re-program the latter to support tumor growth ([@R41]). In addition, accumulating evidence suggests that chemokines produced by bone marrow-derived mesenchymal stem cells (BM-MSC) play a key role in promoting tumor growth and progression ([@R38]). For example, it has been shown recently that BM-MSCs can be programmed for promotion of tumor invasion when exposed to breast cancer cell-conditioned medium ([@R27]). Work by the Weinberg group also demonstrates that BM-MSCs in tumor stroma are induced to secrete the chemokine CCL5 (RANTES), which in turn enhances the migration, invasion, and metastatic capacity of the tumor ([@R21]). In addition, a recently published study indicates that IL-6 secreted by bone marrow stromal cells creates a bone marrow microenvironment supporting growth and metastasis of neuroblastoma cells ([@R3]). In this regard, it is noteworthy that cytokine profiles produced from adipose-derived stem cells are similar to those displayed by bone marrow-derived stem cells, with IL-6 and IL-8 being the most abundantly expressed chemokines amongst a variety of others ([@R23]).

Our in vitro study clearly implicates the role of ASC-secreted IL-6 in promoting tumor cell migration of ER-positive and ER-negative breast cancer cells. This finding is in line with previously published data showing the growth promoting effect of IL-6 ([@R34]; [@R40]). IL-6 secretion increases with body mass and obese patients have greatly elevated IL-6 serum levels ([@R18]). Furthermore, high serum level of IL-6 is a viable marker for poor prognosis in breast cancer patients ([@R19]). It is conceivable that high IL-6 serum levels provide an environment that is conducive to tumor growth and progression ([@R13]; [@R39]), which offers a reasonable explanation for the poor survival rates of obese breast cancer patients ([@R24]).

Depletion of IL-6 from the ASC-conditioned medium did not totally abolish the ASC-mediated stimulatory effect on migration and invasion of the breast cancer cells. This could be due to incomplete depletion of IL-6 from the conditioned medium. Alternatively, additional factor(s) in the ASC conditioned medium may also contribute to the tumor-promoting effect of ASCs. Consistent with this possibility, the cytokine blotting used in this work indicates differential levels of additional factors secreted by the control and Cofilin-knockdown ASCs. It will be of importance to determine whether IL-6 could act synergistically with another putative ASC-secreted factor to promote tumor invasion.

Our finding does not exclude an additional effect of ASCs in guiding tumor cell invasion through physical contact with the tumor cells in vivo. It was recently reported that fibroblasts are capable of generating tracks and leading the movement of carcinoma cells when the two cell types were in physical contact ([@R12]). Given the highly migratory nature of the ASC itself (M.W. and R.L., unpublished data), it is conceivable that the cytokine-producing and track-generating capabilities of ASC may both contribute to its observed tumor invasion-promoting effect *in vivo*.

The function of Cofilin-1 has been extensively characterized in epithelial cells. By severing actin filaments (F-actin), Cofilin-1 can increase the number of free barbed ends for polymerization and at the same time replenish the pool of monomeric G-actin in the cells ([@R36]; [@R47]). Deregulation of the Cofilin-1-mediated pathways in breast tumor cells is a critical determinant for the invasive and metastatic phenotype of tumor cells ([@R47]). However, function of the same actin-regulatory pathways in the stromal compartment of the tumor microenvironment is not well understood. Our study strongly implicates a Cofilin-1-dependent pathway in controlling the gene expression level of IL-6, which is distinct from its well-recognized role in supporting cytoskeleton dynamics. While the exact mechanism by which Cofilin-1 regulates IL-6 production remains to be elucidated, we envision the following two possible scenarios. First, Cofilin-1-mediated cytoskeleton dynamics may lead to changes in the activity of a number of kinases known to be associated with the cytoskeleton network. Alternatively, Cofilin-1 may influence the location and activity of nuclear actin, which has been shown to more directly regulate transcription via its interactions with various transcription factors, chromatin remodeling complexes, and even RNA polymerase II itself ([@R35]). Regardless of the underlying mechanism, we speculate that excessive adiposity may exert significant stress on cellular structure and maintenance of the stress fibers in ASCs. Constant activation of the Cofilin-1 pathway may therefore result in increased expression and secretion of cytokines like IL-6. Weight loss via pharmacological intervention or physical activity in obese breast cancer patients may greatly improve their survival by reducing the adipose production of inflammatory factors. Furthermore, given the known function of Cofilin-1 pathway in breast tumor cells, simultaneous blockage of the Cofilin-1 pathway in tumor and the surrounding stromal cells may provide an effective way to blunt tumor invasion.

Adiposity is often equated with the abundance of the fully differentiated, fat-laden mature adipocytes. However, adipose tissue contains a variety of other resident cell types including preadipocytes. While it was reported that mature adipocytes rather than preadipocytes are promoters of breast carcinoma growth ([@R31]), more recent work demonstrated the involvement of both adipocytes and preadipocytes in promoting the proliferation of colon cancer cells ([@R2]). The complex composition of adipose tissue is reflected by the presence of various precursors of adipocytes at earlier stages of adipogenesis, as evidenced by the isolation and characterization of ASCs for their regenerative potentials ([@R15]; [@R46]). Similar to multipotent adult stem cells from other tissues, ASCs display extensive developmental plasticity, as evidenced by their ability to differentiate into multiple lineages including adipocytes, osteoblasts, chondrocytes, and myocytes, etc. In our study, ASCs isolated from either abdominal or breast adipose tissue greatly increased migration of both ER-positive and ER-negative breast tumor cells, suggesting that the induction of tumor cell migration and invasion is independent of the source of fat depot and estrogenic function of ASCs. The recent identification of white fat progenitor cells in the mouse adipose vasculature provides more insight into the molecular identity and locations of these adipocyte pregenitor cell population ([@R44]). Therefore, it will be of importance to determine in future work whether human ASCs and mouse fat progenitor cells share the same property in stimulating tumor cell migration and invasion.

While most of the published work has focused on the tumor-promoting activity of stromal cells in response to the initial activating cue from tumor cells, the current work reveals an innate capability of ASCs from cancer-free individuals to promote tumor cell migration and invasion. Adipose tissue is not only a fat depository, but also an important endocrine organ that releases a wide variety of chemokines or adipokines ([@R1]). Obesity is characterized by a vast increase in fat cell size and number ([@R43]). Moreover, obesity is associated with an altered cytokine profile, characterized by a reduction in the release of anti-inflammtory cytokines such as adiponectin and a concurrent increase in secretion of pro-inflammatory cytokines ([@R11]). Consequently, obesity is considered to be an important source of chronic inflammation. Prolonged exposure to high levels of pro-inflammatory cytokines secreted by ASCs in adipose tissue prior to tumor formation may provide an environment conducive to the initiation and subsequent development of breast cancer. It will be of interest to determine in future work whether the tumor migration-promoting activity of ASCs varies in the general population and if so, whether it serves as a predisposing factor for breast cancer development.

METHODS AND MATERIALS {#S8}
=====================

Cell culture and reagents {#S9}
-------------------------

The human breast cancer cell line MCF-7 was obtained from the American Type Culture Collection (ATCC, Rockville, MD). MDA-MB-231-GFP and the primary human fibroblast cells (CRL2703) were previously reported ([@R30]). Human adipose stromal cells (ASCs) were isolated from abdominal and breast adipose tissue from cancer-free donors undergoing liposuction and reduction mammoplasty, respectively, using previously published protocols ([@R14]). For all experiments, ASCs between passages 4 and 10 were used.

Boyden-chamber transmigration assay {#S10}
-----------------------------------

Untreated or siRNA-treated ASCs were plated (4×10^4^ cells/0.5 ml DMEM/F12 plus FBS) in a 24-well plate (cat.\# 353504, BD Biosciences, Bedford, MA) and incubated for 48h at 37°C. MDA-MB-231-GFP (5×10^4^ cells/0.2 ml) were placed in the upper compartment of the Boyden-chamber system, using Boyden-chamber inserts fitted with 3 micron pore membranes (BD Biocoat cat.\# 354575). For experiments using MCF-7 cells, 2×10^5^ cells/0.2 ml were loaded into the Boyden-chamber inserts fitted with 8 micron pore membranes (BD BioCoat cat.\# 354578). MDA-MB-231-GFP cells were assayed for 7 h and MCF-7 cells for 24 h. At the end of the assay, inserts were removed and the cells were fixed in 4% paraformaldehyde and then stained with a 0.1% Crystal-Violet solution. Tumor cells on the upper membrane surface were removed with a paper towel. The air-dried membranes were viewed under 20x magnification and migrated cells were counted in 3 randomly chosen fields per membrane. Each cell line was assayed at least three times and assays were performed in triplicate. Error bars show standard deviation (SD). For invasion assays, Matrigel-coated inserts with 8 micron pore membranes (BD BioCoat cat.\# 354480) were used. MDA-MB-231-GFP cells (5×10^4^ cells/0.2 ml) were processed in the same manner as the migration assay.

Wound-healing migration assay {#S11}
-----------------------------

MDA-MB-231-GFP cells (4×10^4^ cells/0.5 ml) were plated into silicone cell culture inserts (quadriPERM, cat.\# Z376647, Sigma-Aldrich, St, Louis, MO) that had been placed into a 35 mm Petri-dish. The control medium was DMEM + 10% FBS while the conditioned medium consisted of DMEM + 10% FBS supplemented with ASC supernatant. The cells were incubated for 48 h at 37°C. The cell monolayer was scraped with a pipette tip to create a wound. Closure of the wound was monitored with a NIKON BioStation IM Time Lapse Imaging System at 5 randomly chosen fields per sample in 15-min intervals over a period of 24 h. The speed of wound-closure or velocity of the moving cell fronts was measured at 3 different points per field using NIS -- Elements Advanced Research (V 3.0) software. Statistical analysis was performed by an unpaired Student's *t*-test.

Xenograft in immunodeficient mice {#S12}
---------------------------------

Male and female immunodeficient mice (RAG2^−/−^ γc^−/−^, Taconic, Germantown, NY) at the age of \> 6 weeks and with an average weight of ∼ 25 g were used in this experiment. Procedures were executed in accordance with the National Institutes of Health (NIH) Guide for the Use and Care of Laboratory Animals. Cell transplantations were performed as described previously ([@R29]). Either MDA-MB-231-GFP cells (2 × 10^6^ cells) alone or mixed with an equal number of ASCs were injected under the renal capsule. Two weeks after cell transplantation, xenografts were fixed in 4% paraformaldehyde and processed by conventional methods as described in ([@R29]). Penetration of the invading cell front into the host kidney was measured under 100x magnification. Statistical analysis was performed by an unpaired Student's *t*-test.

RNA isolation and real-time RT-PCR {#S13}
----------------------------------

Total RNA was extracted using the TRIzol method according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). 1 µg of total RNA was then used to produce cDNA by reverse transcription using random primers of the ImPrompII Reverse Transcription System kit (Promega, Madison, WI). SYBR Green-based RT-PCR was carried out in a 7900 HT Real-Time PCR System (Applied Biosystems) according to the manufacturer's instructions. The primer sets used in these experiments are listed in [Suppl. Table 1](#SD5){ref-type="supplementary-material"}. Values for each gene were normalized to the expression levels of 18S rRNA.

siRNA knockdown {#S14}
---------------

Dharmacon siGENOME SMARTpool oligos were purchased from Thermo Fisher Scientific (Lafayette, CO). Catalog numbers for the specific siRNA oligo pools are listed in [Suppl. Table 2](#SD6){ref-type="supplementary-material"}. 1 × siRNA buffer (cat.\# B-002000-UB-015) was used in mock and OTP (cat.\# M-013549-00) in control transfections. siRNA knockdown experiments were carried out as described previously ([@R14]). In brief, ASCs at ∼ 60% confluency were transfected with Lipofectamine RNAiMax reagent (Invitrogen, Carlsbad, CA) in Opti-MEM (GIBCO) and siRNA oligos at a concentration of 20 nM overnight. Individual siRNA oligo sets were also tested at a final concentration of 10 nM (cat.\# D-012707-03, −04).

Immunoblotting {#S15}
--------------

After electrophoretic separation and immunoblotting of whole ASC lysates, Cofilin-1 was detected with a mouse monoclonal anti-Cofilin-1 antibody (Santa Cruz Biotechnology, CA) and α-Tubulin with a mouse monoclonal anti-α-Tubulin antibody (CalBiochem, La Jolla, CA).

Cytokine Antibody Array {#S16}
-----------------------

An antibody-based cytokine array system was used to detect the levels of cytokines and growth factors in supernatants from ASCs that had been either treated with a control siRNA or Cofilin-1 siRNA. In order to minimize the effect of exogenous cytokines and growth factors in FBS, the FBS concentration in the ASC-culturing medium was decreased to 1% (v/v). The experiment was carried out using the RayBio Human Cytokine Array V kit (cat.\# AAH-CYT-5) from RayBiotech (Norcross, GA) following the manufacturer's instructions. siRNA-treated ASCs were incubated with culture medium for 2 days. The cell-free supernatant was used undiluted. All incubation steps were carried out overnight at 4°C.

IL-6 antibody depletion {#S17}
-----------------------

Culture medium and ASC-conditioned culture medium were incubated with 2 µg/ml of a mouse monoclonal anti-hIL6-antibody or a mouse monoclonal IgG~1~ (R&D Systems, Minneapolis, MN) for 4 h on a rotary shaker at 4°C. Protein G-Agarose beads (Roche, Indianapolis, IN) were then added and incubation continued overnight at 4°C. The beads were removed by centrifugation. The supernatant was warmed at 37°C and subsequently used in a Boyden-chamber assay as described above.

Supplementary Material {#SM}
======================
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![ASCs promote migration and invasion of breast cancer cells\
**(A)** Boyden-chamber migration assay. ASCs isolated from breast and abdominal adipose tissue and a skin fibroblast cell line were plated in 24-well plates for 48h. Normal growth medium without cells was used as control. MDA-MB-231 cells or MCF-7 cells were loaded in the upper chambers. MDA-MB-231 cells were assayed after 7 h and MCF-7 cells after 24 h. The top panels illustrate the migrated MDA-MB-231 cells. **(B)** Matrigel-based invasion assay. Abdominal ASCs were plated as described above in normal growth medium. MDA-MB-231 cells were loaded on the top chambers coated with Matrigel. The breast tumor cells were allowed to invade for 7 h. Columns are the mean of a representative experiment assayed in triplicate and normalized to the control column. In this and following figures, error bars = standard deviation (SD). All experiments were repeated at least 3 times.](nihms111638f1){#F1}

![ASCs promote MDA-MB-231 cell invasion in a xenograft mouse model\
MDA-MB-231-GFP cells either alone or with ASCs were transplanted under the renal capsule of immunodeficient mice (n=4 per treatment). The mice were sacrificed 2 weeks after transplantation. Sections were stained with a GFP-specific antibody for visualizing the GFP-expressing breast tumor cells. MDA-MB-231-GFP cells appear brown and mouse renal cells blue as a result of hematoxylin counter-staining. **(A)** Panels a and b show MDA-MB-231 transplanted alone, magnification x20 and x100, respectively. Panels c and d show MDA-MB-231 cells co-transplanted with ASCs. The white bars stand for 200 µm. **(B)** The depth of breast tumor cells invading into the mouse kidney tissue was used as a measure of invasiveness.](nihms111638f2){#F2}

![siRNA knock-down of Cofilin-1 in ASCs reduces their migration-promoting activity\
**(A)** Cofilin-1 knocked down in ASCs by siRNA using an oligo pool and individual oligos. α-Tubulin is used as loading control. **(B)** Cofilin-1-knockdown ASCs were tested in the Boyden-chamber migration assay using MDA-MB-231 cells.](nihms111638f3){#F3}

![The migration-promoting activity of ASCs is controlled by the Cofilin-1 signaling pathway\
**(A)** A diagram illustrating the Cofilin-1-dependent pathway, adapted from Wang et al. ([@R47]). **(B)** siRNA knockdown of several players of the Cofilin-1 pathway reduced the migration-promoting activity of ASCs. **(C)** Pre-treatment of ASCs with the specific Rock inhibitor Y27632 reduced the migration-promoting activity of ASC in a dose-dependent manner. All experiments were carried out in triplicate and repeated at least 3 times.](nihms111638f4){#F4}

![siRNA knock down of Cofilin-1 in ASCs results in reduced production of IL-6\
**(A)** MDA-MB-231 migration assay using growth medium alone or ASC-conditioned medium, with or without Cofilin-1 knockdown. **(B)** Antibody-based cytokine array (RayBio^®^) using conditioned medium from control and Cofilin-1 knockdown ASCs. Experiment was repeated twice. **(C)** RT-PCR of IL-6 in ASCs transfected either with control or Cofilin-1 siRNA. All experiments were carried out in triplicate.](nihms111638f5){#F5}

![IL-6 depletion reduces the migration and invasion-promoting effect of ASCs\
**(A)** IL-6 was removed from ASC-conditioned medium by incubation with a mouse monoclonal IL-6 specific antibody. An isomeric IgG was used as control antibody. The Boyden-chamber migration assay was conducted as shown in the previous figures. **(B)** Matrigel-based invasion assay of MDA-MB-231 cells using control or IL-6-depleted ASC-conditioned medium. Experiments were carried out in triplicate and repeated three times. Columns were normalized to Control Medium + IgG.](nihms111638f6){#F6}
